| |
| | Increased Frequency of Expression of Elevated Dihydrofolate Reductase in T-Cell Versus B-Precursor Acute Lymphoblastic ... |
 | | The relationships between dihydrofolate reductase (DHFR) levels or methotrexate membrane transport and acute lymphoblastic leukemia (ALL) immunophenotype were evaluated on 51 T-cell and 44 B-precursor ALL specimens from 90 pediatric ALL patients at diagnosis and relapse, using a fluorescent methotrexate analog (PT430) and flow cytometry assay (Matherly et al, Blood 85:500, 1995). |
 | | Hence, ALL patients' lymphoblasts exhibit low-level dihydrofolate reductase (DHFR) gene amplification (2- to 4-fold) and increased DHFR expression at diagnosis and relapse. |
 | | Goker E, Waltham M, Kheradpour A, Tippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinhertz P, Tan C, Berman E, Bertino JR: Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. |
| www.bloodjournal.org /cgi/content/full/90/2/578 (6325 words) |
|